In dual-luciferase reporter gene assays, Smad7 was shown to be negatively regulated by miR-182-5p; therefore, inhibiting miR-182-5p can be regarded as an effective method for treating idiopathic pulmonary fibrosis (IPF) (33). This evidence concerns the gene SMAD7 and idiopathic pulmonary fibrosis.